NUVALENT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.02 USD | +2.94% |
|
-0.90% | -7.57% |
| 05-09 | Nuvalent Q1 Net Loss Widens | MT |
| 05-09 | Nuvalent, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NUVALENT, INC. | Other Biotechnology & Medical Research | +2.94% | -0.90% | -7.57% | +72.64% | - | 4.27B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- NUVL Stock
- Charts Nuvalent, Inc.
- Comparison Chart
